基于NCA029的形状互补策略使强大的HsClpP激动剂能够用于治疗小细胞肺癌
Linjie Li1, Baozhu Luo1, Xudong Wang2
1Cancer Center and State Key Laboratory of Biotherapy, and Laboratory of Human Diseases and Immunotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
European journal of medicinal chemistry
|August 14, 2025
概括
研究人员开发了一种新型化合物,8o,可以激活HsClpP来对抗小细胞肺癌 (SCLC). 在临床前模型中,这种强有力的激动剂显示出更好的疗效和安全性,抑制癌细胞生长和瘤进展.
科学领域:
- 生物化学和分子生物学
- 癌症治疗方法 癌症治疗方法
- 药物发现 药物发现 药物发现
背景情况:
- 热冲击蛋白ClpP (HsClpP) 的激活对线粒体平衡至关重要,并提出了潜在的癌症治疗策略,特别是在小细胞肺癌 (SCLC) 中.
- 之前的研究确定了NCA029作为一种非皮 HsClpP激动剂,作为开发更强效衍生物的基础.
研究的目的:
- 设计和合成具有增强结合亲和力和抗癌活性的新型HsClpP激动剂.
- 在SCLC和其他癌症的临床前模型中评估化合物的疗效和安全性.
主要方法:
- 采用了形状互补策略来设计和合成基于NCA029支架的一系列HsClpP激活剂.
- 评估了结合亲和力,并使用SCLC细胞系 (H69和H82) 的IC50值确定了细胞功效.
- 在非SMC异种移植模型中评估了体外和体内安全性,药理动力学特性和抗瘤疗效.
主要成果:
- 与NCA029相比,化合物8o对HsClpP的结合亲和力增加了5倍,这归因于额外的环状结构.
- 8o强烈抑制的SCLC细胞系 (H69:IC50 = 0.17μM;H82:IC50 = 0.19μM),显著优于NCA029.
- 化合物8o表现出改善的安全性,良好的药理动力学,并在体内达到高达63.01%的瘤生长抑制.
结论:
- 新型HsClpP激动剂,化合物8o,代表了SCLC和潜在的其他癌症的有希望的治疗候选者.
- 在临床前模型中,其增强的功效,改善的安全性和有效性需要进一步研究临床开发.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K